Scientific Literature Search

Source record

[Therapy of Parkinson disease. Continuous physiologic dopaminergic stimulation with carbergoline].

Check source for author details

Nervenarzt · 1997-03-01

PMID: 9404531

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Dopaminergic neurons protected from degeneration by GDNF gene therapy.

Choi-Lundberg DL, Lin Q, Chang YN, Chiang YL, Hay CM, Mohajeri H, Davidson BL, Bohn MC.

Science · 1997-02-01

DOI: 10.1126/science.275.5301.838PMID: 9012352

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Drug treatment of Parkinson's disease in the 1990s. Achievements and future possibilities.

Hughes AJ.

Drugs · 1997-02-01

DOI: 10.2165/00003495-199753020-00002PMID: 9028741

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.

Giménez-Roldán S, Tolosa E, Burguera JA, Chacón J, Liaño H, Forcadell F.

Clin Neuropharmacol · 1997-02-01

DOI: 10.1097/00002826-199702000-00008PMID: 9037575

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group.

Rinne UK, Bracco F, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL, Marsden CD, Dubini A, Orlando N, Grimaldi R.

Neurology · 1997-02-01

DOI: 10.1212/wnl.48.2.363PMID: 9040722

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Current therapy of Parkinson's disease.

Ajax T, Rodnitzky R, Dobson J.

Iowa Med · 1997-02-01

PMID: 9055504

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Neurodegeneration: aging and dementia. Etiopathogenic role of electron transport disorders. Therapeutic possibilities].

Klivényi P, Vécsei L.

Orv Hetil · 1997-02-01

PMID: 9082290

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy].

Fuchs G.

Fortschr Med · 1997-02-01

PMID: 9162718

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Radiosurgical lesioning of the caudate nucleus as a treatment for parkinsonism: a preliminary report.

Friehs GM, Ojakangas CL, Schröttner O, Ott E, Pendl G.

Neurol Res · 1997-02-01

DOI: 10.1080/01616412.1997.11740780PMID: 9090645

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Drug therapy in the management of Parkinson's disease.

Stevenson T.

Br J Nurs · 1997-02-01

DOI: 10.12968/bjon.1997.6.3.144PMID: 9104119

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

A clinical and [18F]dopa PET study of the progression of Parkinson's disease and its treatment by embryonic implantation

Morrish PK.

· 1997-01-01

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Is stereotactic surgical treatment still necessary for Parkinson's disease in the contemporary trend of medical therapy with dopamine receptor agonist?

Amano K, Takakura K.

Stereotact Funct Neurosurg · 1997-01-01

DOI: 10.1159/000099849PMID: 9711730

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

21.218 articles found

[Therapy of Parkinson disease. Continuous physiologic dopaminergic stimulation with carbergoline].

Dopaminergic neurons protected from degeneration by GDNF gene therapy.

Drug treatment of Parkinson's disease in the 1990s. Achievements and future possibilities.

Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.

Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group.

Current therapy of Parkinson's disease.

[Neurodegeneration: aging and dementia. Etiopathogenic role of electron transport disorders. Therapeutic possibilities].

[Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy].

Radiosurgical lesioning of the caudate nucleus as a treatment for parkinsonism: a preliminary report.

Drug therapy in the management of Parkinson's disease.

A clinical and [18F]dopa PET study of the progression of Parkinson's disease and its treatment by embryonic implantation

Is stereotactic surgical treatment still necessary for Parkinson's disease in the contemporary trend of medical therapy with dopamine receptor agonist?

Filters